According to The Leukemia & Lymphoma Society:

  • An estimated 750,000 Americans are living with leukemia, lymphoma or myeloma
  • Someone is diagnosed with one of these this diseases approximately every 5 minutes
  • On any given day, approximately 6,000 men, women and children are searching the NMDP Registry.

But, advances have been made:

  • The survival rate for Hodgkin’s Lymphoma is 85%, as opposed to 40% in 1960
  • 86% of children diagnosed will survive, while in 1974, the five-year survival rate for children was only 53%

We are making great strides towards helping patients find matched transplants. But, we need to remember that our commitment does not end with a signature and a sample of our cells. We need to be ready to help when we are called upon as donors. Let’s work together to bring smiles back to life.

What is Leukemia?

Leukemia is the general term used to describe four different disease-types called:

  • Acute Myelogenous Leukemia (AML)
  • Acute Lymphocytic Leukemia (ALL)
  • Chronic Myelogenous Leukemia (CML)
  • Chronic Lymphocytic Leukemia (CLL)

The terms lymphocytic or lymphoblastic indicate that the cancerous change takes place in a type of marrow cell that forms lymphocytes. The terms myelogenous or myeloid indicate that the cell change takes place in a type of marrow cell that normally goes on to form red cells, some types of white cells, and platelets.

Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts. Acute leukemia progresses rapidly without treatment.

Chronic leukemias have few or no blast cells. Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.

People can get leukemia at any age. In 2007, about and 40,440 adults and  3,800 children are expected to develop leukemia. It is most common in people over age 60. The most common types in adults are AML and CLL. ALL is the most common form of leukemia in children.

We work to provide hope and deliver a cure to all patients in need. With your support, more patients can access the treatment they so desperately need.

Taken from